Executive Summary
This appeal before the Bombay High Court challenged a trial court order that restrained the appellants from using the artistic label 'Military Santra' for selling country liquor. The appellants argued that the respondent-plaintiff had prior knowledge of the label since 2005 and was therefore acquiescent, invalidating the injunction. Furthermore, they contended that their own usage since 1975 established their copyright in the artwork. The High Court allowed the appeal, setting aside the restrictive order and directing the trial court to expedite the disposal of the main Copyright Suit.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Bombay High Court. Understanding the court's reasoning in Brihan Karan Sugar Syndicate Private Limited vs Karmaveer Shankarrao Kale Shahakari Sakhar Karkhana Limited is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Minda Spectrum Advisory Limited & Ors.vsAb Petrochem
The Delhi High Court granted an ex-parte ad-interim injunction in favor of Minda Spectrum Advisory Limited & Ors. against Ab Petrochem, recognizing the Plaintiffs' established rights over the MINDA trademark and its variants. The court found that the Defendant was operating under infringing marks (AB MINDA) in the oil and grease sector. To enforce this interim relief, a Local Commissioner was appointed to visit the Defendant's premises, seize infringing goods, and inventory relevant business records.
Mankind Pharma Ltd.vsGurinder Singh
The Delhi High Court allowed Mankind Pharma Ltd.'s petition seeking the cancellation of a competing trademark registered by Gurinder Singh. The court held that due to Mankind's long-standing use and established goodwill, its marks (including 'MANKIND' and the 'KIND' family) had acquired well-known status. Consequently, the registration of the impugned mark was deemed violative of Sections 11(1) and 11(2) of the Trademarks Act, leading to its removal from the register.
Astellas Pharma IncvsEverest Pharmaceuticals Limited
Astellas Pharma Inc filed a suit seeking permanent injunction and damages for the infringement of its Indian Patent No. 292990 by Everest Pharmaceuticals Limited and others. The court passed several orders, including granting an ex-parte ad-interim injunction against Defendants 8 and 9 to cease marketing and listing of the infringing product GILTERNIB.
Glaxosmithkline Pharmaceuticals LimitedvsChembott Chemicals And Pharmaceutical Private Limited and Anr
The Delhi High Court granted an ad-interim injunction in favor of Glaxosmithkline Pharmaceuticals against Chembott Chemicals. The court found that the plaintiff had made out a strong prima facie case regarding the infringement of its registered trademark, 'COBADEX', by the defendants' mark, 'COZIDEX'. Given the nature of pharmaceutical products and the potential for irreparable harm to both parties and the public, the injunction was granted immediately until the next hearing date.
Classic Legends Private Limited / Mr. Boman R. IranivsThe Official Liquidator of M/S Ideal Jawa Private Limited
The Karnataka High Court allowed appeals filed by Classic Legends Private Limited (and Mr. Boman R. Irani) against an earlier ruling concerning the trade marks of Ideal Jawa. The court ruled that since the company had not used or renewed its registered trade marks for decades, no goodwill would subsist, and the rights had dissipated due to non-use. This decision significantly impacts the value and enforceability of the brand in liquidation proceedings.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.